Status: Recruiting
Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial
This study is testing a shorter treatment method for prostate cancer using proton therapy (PT), which is very precise and may cause fewer side effects compared to traditional radiation. However, it is expensive and not easily accessible for many patients. To make it more affordable and accessible, this study is testing whether 2 fractions of stereotactic body proton therapy (SBPT) can be as safe and effective as the standard 5 sessions.
Participants needed: 35
Trial details
Biological sex: MaleType: InterventionalSponsor: Hong Kong Sanatorium & HospitalUpdated: Mar 16, 2026Locations: 1
Eligibility criteria
Men aged < 18 years with histologically confirmed low- or intermediate-risk pros... [+3]
History of inflammatory bowel disease or other cancers (except prostate cancer) [+7]